The utilization of VEGF inhibitors bevacizumab and VEGFR2 inhibitors can reduce tumor growth and promote cell senescence, which is associated with the p16 and p21 levels, respectively (88, 89). The gene discussed is VEGFA; the disease is neoplasm.